Crossmark

Efficacy of cidofovir versus bevacizumab in recurrent respiratory papillomatosis: A randomized, double-blind, placebo-controlled pilot study

Crossref DOI link: https://doi.org/10.1016/j.otoeng.2020.12.001

Published Print: 2022-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ablanedo-Terrazas, Yuria

Estrada-Camacho, Oscar

Alvarado-de la Barrera, Claudia

Ramírez-García, Arturo

Tona-Acedo, Gabriel

Bross-Soriano, Daniel

Schimelmitz-Idi, José
License Information

Text and Data Mining valid from 2022-03-01
More Information

This article is maintained by: Elsevier

Article Title: Efficacy of cidofovir versus bevacizumab in recurrent respiratory papillomatosis: A randomized, double-blind, placebo-controlled pilot study

Journal Title: Acta Otorrinolaringologica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.otoeng.2020.12.001

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.otorri.2020.12.001

Content Type: article

Copyright: © 2021 Sociedad Española de Otorrinolaringología y Cirugía de Cabeza y Cuello. Published by Elsevier España, S.L.U. All rights reserved.